Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial.
Saved in:
| Title: | Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial. |
|---|---|
| Authors: | Laurence V; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France., Jehanno N; Department of Nuclear Medicine, Curie Institute, Paris, France., Dureau S; Department of Biometry, Curie Institute, Saint Cloud, France., Mous L; Balgrist University Hospital, Faculty of Medicine, University of Zurich (UZH), Zurich, Switzerland., Claude L; Department of Radiation Oncology, Centre Léon Bérard, Lyon, France., Ballet S; Genetics Department Curie Institute & PSL Research University, Paris, France., Pierron G; Genetics Department Curie Institute & PSL Research University, Paris, France., Gaspar N; Department of Oncology for Children and Adolescents, Gustave Roussy Institute, Villejuif, France., Brahmi M; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Valentin T; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Revon-Rivière G; Department of Pediatric Hematology, Immunology and Oncology, APHM - La Timone Children's Hospital, Marseille, France., Lervat C; Department of Pediatric and AYA Oncology, Centre Oscar Lambret, Lille, France., Probert J; Department of Pediatric Onco-hematology, University Hospital of Rennes, Rennes, France., Entz-Werle N; Department of Pediatric Onco-hematology, University Hospitals of Strasbourg, Strasbourg, France., Mansuy L; Department of Pediatric Hematology and Oncology, Children's University Hospital, Nancy, France., Plantaz D; Department of Pediatric Hematology and Oncology, University Hospital of Grenoble, Grenoble, France., Rios M; Department of Medical Oncology, Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-lès-Nancy, France., Saumet L; Department of Pediatric Onco-Hematology, University Hospital of Montpellier, Montpellier, Languedoc-Roussillon, France., Vérité C; Department of Pediatric and Adolescent Hematology and Oncology, Pellegrin Hospital, Bordeaux, France., Castex MP; Pediatric Oncology Immunology Hematology Unit, Children's University Hospital - Toulouse University Hospital, Toulouse, France., Thebaud E; Department of Pediatric Oncology, Hôpital Mère-Enfant, Nantes, France., Cassou-Mounat T; Nuclear Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Plissonnier AS; DREH Pôle Promotion, Institut Curie, Saint-Cloud, France., Dieppedale J; Department of Biometry, Curie Institute, Saint Cloud, France., Delattre O; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, SIREDO Oncology Center, Curie Institute Research Center, PSL Research University, Paris, France., Legrier ME; DREH Pôle Promotion, Institut Curie, Saint-Cloud, France., Marec-Bérard P; Department of Pediatric Oncology, Institute for Paediatric Haematology and Oncology, Centre Léon Bérard, Lyon, France., Gouin F; Department of Surgical Oncology, Centre Léon Bérard, Lyon, France., Berlanga P; Department of Oncology for Children and Adolescents, Gustave Roussy Institute, Villejuif, France., Cordero C; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France., Surdez D; Balgrist University Hospital, Faculty of Medicine, University of Zurich (UZH), Zurich, Switzerland., Corradini N; Department of Pediatric Oncology, Institute for Paediatric Haematology and Oncology, Centre Léon Bérard, Lyon, France. nadege.corradini@ihope.fr. |
| Source: | British journal of cancer [Br J Cancer] 2026 Jan; Vol. 134 (2), pp. 279-288. Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
